Scholarlink

Background <p>Leptospirosis is a worldwide re-emerging zoonotic infectious disease caused by pathogenic spirochetes of the <i>Leptospira</i> genus. The clinical symptoms at leptospirosis onset are similar to those of other febrile illnesses, and early etiological identification of pathogenic <i>Leptospira</i> spp. is crucial to initiate immediate treatment and limit transmission. Here, we report a new molecular diagnostic assay termed loop-mediated isothermal amplification combined with a visual gold nanoparticle-based lateral flow biosensor (LAMP-AuNP-LFB) for rapid, specific, sensitive, and visual identification of pathogenic <i>Leptospira</i> strains.</p> Methods <p>The AuNP-based LFB used here was successfully manufactured according to our device manual. The successful design of our unique <i>Leptospira</i>-LAMP primers was based on the <i>lipL41</i> gene from reference strains of 15 serovars representing 15 serogroups of pathogenic <i>Leptospira</i> spp. in China. The reaction conditions, including amplification temperature and time, were optimized, and the sensitivity and specificity of our assay were verified. The feasibility of our assay was tested through field mouse and leptospirosis clinical samples.</p> Results <p>The AuNPs-based LFB used our study was successfully manufactured. The unique pathogenic <i>Leptospira</i> degenerate primers were successfully designed based on the <i>lipL41</i> gene. The optimal <i>Leptospira-</i>LAMP-AuNP-LFB detection process, including rapid nucleic acid isolation (less than 5&#xa0;min), LAMP reaction (67&#xa0;°C for 35&#xa0;min), and visual AuNP-LFB readout (less than 2&#xa0;min), could be accomplished within 45&#xa0;min. Our assay detected target genes with as few as 5 copies per test and showed no cross-reactivity with other microbes in our study. The <i>Leptospira</i>-LAMP-AuNP-LFB assay results were consistent with culture-sequencing results in field mouse and leptospirosis clinical samples.</p> Conclusions <p>The <i>Leptospira-</i>LAMP-AuNP-LFB assay is a valuable tool and has tremendous potential as a point-of-care (POC) testing approach for screening for pathogenic <i>Leptospira</i> infection, especially in resource-poor settings.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Nanoparticle-based biosensors coupled with loop-mediated isothermal amplification for rapid, visual, and in-field identification of pathogenic Leptospira

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月29日

查看全文
  • Ling Xie,
  • Ying Liu,
  • Xinggui Yang,
  • Shijun Li,
  • Xu Chen

摘要

Background

Leptospirosis is a worldwide re-emerging zoonotic infectious disease caused by pathogenic spirochetes of the Leptospira genus. The clinical symptoms at leptospirosis onset are similar to those of other febrile illnesses, and early etiological identification of pathogenic Leptospira spp. is crucial to initiate immediate treatment and limit transmission. Here, we report a new molecular diagnostic assay termed loop-mediated isothermal amplification combined with a visual gold nanoparticle-based lateral flow biosensor (LAMP-AuNP-LFB) for rapid, specific, sensitive, and visual identification of pathogenic Leptospira strains.

Methods

The AuNP-based LFB used here was successfully manufactured according to our device manual. The successful design of our unique Leptospira-LAMP primers was based on the lipL41 gene from reference strains of 15 serovars representing 15 serogroups of pathogenic Leptospira spp. in China. The reaction conditions, including amplification temperature and time, were optimized, and the sensitivity and specificity of our assay were verified. The feasibility of our assay was tested through field mouse and leptospirosis clinical samples.

Results

The AuNPs-based LFB used our study was successfully manufactured. The unique pathogenic Leptospira degenerate primers were successfully designed based on the lipL41 gene. The optimal Leptospira-LAMP-AuNP-LFB detection process, including rapid nucleic acid isolation (less than 5 min), LAMP reaction (67 °C for 35 min), and visual AuNP-LFB readout (less than 2 min), could be accomplished within 45 min. Our assay detected target genes with as few as 5 copies per test and showed no cross-reactivity with other microbes in our study. The Leptospira-LAMP-AuNP-LFB assay results were consistent with culture-sequencing results in field mouse and leptospirosis clinical samples.

Conclusions

The Leptospira-LAMP-AuNP-LFB assay is a valuable tool and has tremendous potential as a point-of-care (POC) testing approach for screening for pathogenic Leptospira infection, especially in resource-poor settings.